Drug Discovery Services Market Report 2026

Drug Discovery Services Market Overview

• Drug Discovery Services market size has reached to $20.52 billion in 2025 • Expected to grow to $39.79 billion in 2030 at a compound annual growth rate (CAGR) of 14.4% • Growth Driver: The Symbiotic Surge Of Chronic Diseases And The Drug Discovery Services Market • Market Trend: Eurofins Discovery Launches Discoveryai SAFIRE To Revolutionize Drug Discovery With AI And ML • North America was the largest region in 2025.

What Is Covered Under Drug Discovery Services Market?

Drug discovery services refer to the procedure for identifying potential new medicines. It combines many scientific disciplines, including biology, chemistry, and pharmacology. These drug discovery services are offered in four stages: early drug discovery, pre-clinical phase, clinical phases, and regulatory approval. The main types of drug discovery services are chemistry services and biology services. The chemistry services refer to designing and synthesizing biologically active molecules to discover and optimize chemical compounds for drug discovery. Chemistry services use high-performance liquid chromatography and high-field NMR to quickly and easily synthesize, analyze, and purify compound libraries. The processes include target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation that use drugs such as biologics and small molecules. The end-users of drug discovery services include pharmaceutical and biotechnology companies, academic institutes, and other end-users.

What Is The Drug Discovery Services Market Growth Forecast?

The drug discovery services market size is expected to see rapid growth in the next few years. It will grow to $39.79 billion in 2030 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to precision medicine pipelines, ai-driven discovery platforms, startup biotech funding, complex disease research, faster lead optimization needs. Major trends in the forecast period include increasing outsourcing of drug discovery activities, growing use of ai in target identification, expansion of early-stage discovery services, rising demand for biologics drug discovery, integration of in vitro and in vivo studies.

Global Drug Discovery Services Market Segmentation

1) By Type: Chemistry Services, Biology Services 2) By Process: Target Selection, Target Validation, Hit-To-Lead identification, Lead Optimization, Candidate Validation 3) By Drug Type: Biologics Drug , Small Molecule Drug 4) By End user: Pharmaceutical And Biotechnology Companies, Academic Institutes, Other End Users Subsegments: 1) By Chemistry Services: Medicinal Chemistry, Compound Management, High-Throughput Screening, Lead Optimization 2) By Biology Services: In Vitro Studies, In Vivo Studies, Pharmacokinetics And Pharmacodynamics (PK Or PD), Biomarker Discovery

What Is The Driver Of The Drug Discovery Services Market?

The rising prevalence of chronic diseases is expected to propel the growth of drug discovery services market going forward. Chronic diseases refer to long-lasting health conditions that usually cannot be cured but can be managed. Drug discovery services play a vital role in identifying and developing new medications to treat chronic diseases. For instance, in September 2023, according to the World Health Organization, a Switzerland-based intergovernmental public health agency, chronic noncommunicable diseases were responsible for 41 million deaths annually, representing 74% of all global deaths. Therefore, the rising prevalence of chronic diseases will help in the growth of the drug discovery services industry.

Key Players In The Global Drug Discovery Services Market

Major companies operating in the drug discovery services market are Thermo Fisher Scientific Inc., Albany Molecular Research Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, Domainex Ltd., GenScript Biotech Corporation, Pharmaceutical Product Development LLC, Advinus Therapeutics Pvt. Ltd., Jubilant Biosys Ltd., Evotec AG, Syngene International Ltd., Bayer AG, Merck KGaA, Ubiquigent Ltd., Eurofins Scientific SE, AppTec Laboratory Services Inc., GVK Biosciences Private Limited, Aurigene Discovery Technologies Limited, Viva Biotech Holdings, Pharmaron Beijing Co. Ltd., Selcia Limited, Concept Life Sciences Group Limited, BioDuro LLC, ChemPartner Corporation, Aptuit LLC, Sygnature Discovery Limited, Peak Proteins Ltd., SRI International, BioAscent Discovery Limited, Sai Life Sciences Limited, Promega Corporation, MedChemExpress LLC, Aragen Bioscience Inc., WuXi STA, BioNTech SE, Moderna Inc., Gilead Sciences Inc., Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals Inc., Amgen Inc., Bristol-Myers Squibb Company

Global Drug Discovery Services Market Trends and Insights

Major companies operating in the drug discovery services market are innovating advanced technologies, such as artificial intelligence (AI) and machine learning (ML), to enhance the efficiency and accuracy of the drug discovery process. Artificial Intelligence (AI) and Machine Learning (ML) are closely related fields within computer science. AI refers to the development of computer systems that can perform tasks typically requiring human intelligence. ML is a subset of AI that focuses on the use of algorithms and statistical models that enable computers to learn from and make predictions or decisions based on data. For instance, in February 2024, Eurofins Discovery, a France-based company, that support services across various sectors, including pharmaceuticals, announced the launch of innovative platform called DiscoveryAI SAFIRE (Suite of ADMET Predictions for In Silico Refinement and Evaluation). This advanced platform utilizes proprietary datasets, artificial intelligence (AI), and machine learning (ML) to enhance the drug discovery process. SAFIRE is designed to expedite the discovery of new pharmaceuticals by predicting the ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties of molecules.The platform leverages data from Eurofins Discovery's extensive BioPrint database, which has been meticulously curated over years of research.

What Are Latest Mergers And Acquisitions In The Drug Discovery Services Market?

In January 2023, Sygnature Discovery, a UK -based integrated Drug Discovery completed the acquisition of SB Drug Discovery for an undisclosed amount. This acquisition will offer a strategic advantage for both companies, to enable further expansion of the businesses and their capabilities, and forms part of Sygnature’s strategic plan to continuously invest in the expansion of its leading integrated drug discovery solutions. SB Drug Discovery is a UK -based company providing critical data for novel drug development through cell line generation, assay development and compound screening services.

Regional Outlook

North America was the largest region in the drug discovery services market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Drug Discovery Services Market?

The drug discovery services market includes revenues earned by entities by providing pharmaceutical services, drug metabolism and pharmacokinetics (DMPK) services, biological services, and medicinal chemistry. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Drug Discovery Services Market Report 2026?

The drug discovery services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the drug discovery services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.